Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters
Reexamination Certificate
2006-12-05
2006-12-05
Oh, Taylor Victor (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acid esters
C562S488000, C514S569000
Reexamination Certificate
active
07145032
ABSTRACT:
Disclosed and claimed herein are e, e, e malonic acid/acetic acid tri-adducts of buckminsterfullerene of the general formula C60R3, wherein each R is independently selected from groups of the formula ═CR1R2wherein each R1and R2is independently selected from the group consisting of —H and —COOH, provided, however, that at least one of the R1,s and R2,s is a hydrogen. Processes for preparing and uses of the same for treating neuronal injury and for life-extension are also disclosed and claimed herein.
REFERENCES:
patent: 5739376 (1998-04-01), Bingel
patent: 6265443 (2001-07-01), Choi et al.
patent: 6538153 (2003-03-01), Hirsch et al.
patent: WO-97/46227 (1997-12-01), None
Michelle Keaney et al.; Superoxide Dismutase Mimetics Elevate Superoxide Dismutase Activity In Vito But Do Not Retard Aging In The Nematode Caenorhabditis elegans; Free Radical Biology & Medicine, 2004, pp. 239-250, vol. 37, No. 2, Elsevier, Queen Square, London.
Chenxi Wang et al.; Statistical Methods For Testing Effects On “Maximum Lifespan”, Mechanisms of Ageing and Development, 2004, pp. 629-632, Elsevier.
Sameh S. Ali et al.; A Biologically Effective Fullerene (C60) Derivative With Superoxide Dismutase Mimetic Properties, Free Radical Biology & Medicine, 2004, pp. 1191-1202, vol. 37, No. 8; Elsevier.
Rajindar S. Sohal et al.; Oxidative Stress, Caloric Restriction, and Aging, Science; Jul. 5, 1996, pp. 59-63, vol. 273.
Cheol-Koo Lee et al.; Gene Expression Profile of Aging and Its Retardation by Caloric Restriction, Science, Aug. 27, 1999, pp. 1390-1393, vol. 285.
Simon Melov et al.; Extension of Life-Span with Superoxide Dismutase/Catalase Mimetics, Science, Sep. 1, 2000, pp. 1567-1569, vol. 289.
Yoko Honda et al.; Oxidative Stress and Life Span Determination in the Nematode Caenorhabditis elegans, Annals New York Academy of Sciences, 2002, pp. 466-474, New York Academy of Sciences.
Pamela L. Larsen, Aging and resistance to oxidative damage in Caenorhabditis elegans, Procedure National Academy Science USA, Oct. 1993, pp. 8905-8909, vol. 90, Genetics.
Angelo Turturro et al.; Growth Curves and Survival Characteristics of the Animals Used in the Biomarkers of Aging Program, Journal of Gerontology: Biological Sciences, 1999, pp. B492-B501, vol. 54A, No. 11, The Gerontological Society of America.
National Institute on Aging, National Institutes of Health, Interventions Testing Program [retrieved on Jul. 18, 2005]. . Retrieved from the Internet:<URL: http://www.nia.nih.gov/ResearchInformation/ScientificResources/InterventionsTestingProgram.htm.
Henry et al., “Report of the IDECG Working Group on the Biology of Aging,” European Journal of Clinical Nutrition, S:157-159 (2000).
Roth et al., “Caloric Restriction in Primates and Relevance to Humans,” Annals of New York Academy Sciences, vol. 928, pp. 305-315 (2001).
Knoll, “The Striatal Dopamine Dependency of Life Span in Male Rats: Longevity Study with (—)Deprenyl,” Mechanisms of Ageing and Development, vol. 46, pp. 237-262 (1988).
Kitani et al., “Chronic Treatment of (—)Deprenyl Prolongs the Life Span of Male Fischer 344 Rats: Further Evidence,” Life Science, vol. 52, pp. 281-288 (1993).
Carrillo et al., “A High Dose of Long Term Treatment with Deprenyl Loses its Effect on Antioxidant Enzyme Activities As Well As On Survivals of Fischer-344 Rats,” Life Sciences, vol. 67, pp. 2539-2548 (2000).
Ingram et al., “Chronic Treatment of Ages Mice with L-Deprenyl Produces Marked Striatal MAO-B Inhibition But No Beneficial Effects on Survival, Motor Performance, or Nigral Lipofuscin Accumulation,” Neurobiology of Aging, vol. 14, pp. 431-400 (1993).
Jordens et al., “Prolongation of Life in an Experimental Model of Aging inDrosophila Melanogaster,” Neurochemical Research, vol. 24, No. 2, pp. 227-233 (1999).
Birkmayer et al., “Increased Life Expectancy Resulting from Addition of L-Deprenyl to Madopar® Treatment in Parkinson's Disease: A Longterm Study,” Journal of Neural Transmission, vol. 64, pp. 113-127 (1985).
Ben-Shlomo et al., “Investigation by Parkinson's Disease Research Group of United Kingdom into Excess Mortality Seen with Combined Levodopa and Selegiline Treatment in Patients with Early, Mild Parkinson's Disease: Further Results of Randomised Trial and Confidential Inquiry,” British Medical Journal, vol. 316, pp. 1191-1196 (1998).
Quick et al., “Rapid Microplate Assay for Superoxide Scavenging Efficiency,” Journal of Neuroscience Methods, pp. 139-144 (2000).
Krusic et al., “Radical Reactions of C60,” Science, vol. 254, pp. 1183-1185 (1991).
Holden, C., “The Quest to Reverse Time's Toll,” Science, vol. 295, pp. 1032-1033 (2002).
Dugan, L. et al., Carboxyfullerenes as Neuroprotective Agents, Proc. Natl. Acad. Sci, Aug. 1997 94: 9434-9439.
Bosi, S. et al., Fullerene Derivatives: An Attractive Tool for Biological Applications, Euro. J. of Med. Chem. 2003, 38: 913-923.
PCT International Search Report dated Aug. 12, 2004.
Dugan Laura L.
Hardt Joshua I.
Lovett Eva G.
Quick Kevin L.
Oh Taylor Victor
Thompson & Coburn LLP
Washington University
LandOfFree
Therapeutic malonic acid/acetic acid C 60 tri-adducts of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic malonic acid/acetic acid C 60 tri-adducts of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic malonic acid/acetic acid C 60 tri-adducts of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3660914